Article Cited by others

RESEARCH PAPER

Assessment of proarrhythmic activity of chloroquine in in vivo and ex vivo rabbit models

Khobragade Shailaja B, Gupta Pankaj, Gurav Prashant, Chaudhari Girish, Gatne Madhumanjiri M, Shingatgeri Vyas M

Year : 2013| Volume: 4| Issue : 2 | Page no: 116-124

   This article has been cited by
 
1 Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
Gayathri Baburaj, Levin Thomas, Mahadev Rao
Archives of Medical Research. 2021; 52(3): 261
[Pubmed]  [Google Scholar] [DOI]
2 Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19
Annie Delaunois, Matthew Abernathy, Warren D. Anderson, Kylie A. Beattie, Khuram W. Chaudhary, Julie Coulot, Vitalina Gryshkova, Simon Hebeisen, Mark Holbrook, James Kramer, Yuri Kuryshev, Derek Leishman, Isabel Lushbough, Elisa Passini, Will S. Redfern, Blanca Rodriguez, Eric I. Rossman, Cristian Trovato, Caiyun Wu, Jean-Pierre Valentin
Clinical and Translational Science. 2021; 14(3): 1133
[Pubmed]  [Google Scholar] [DOI]
3 Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data
Levin Thomas, Sumit Raosaheb Birangal, Rajdeep Ray, Sonal Sekhar Miraj, Murali Munisamy, Muralidhar Varma, Chidananda Sanju S.V., Mithu Banerjee, Gautham G. Shenoy, Mahadev Rao
Therapeutic Advances in Drug Safety. 2021; 12: 2042098621
[Pubmed]  [Google Scholar] [DOI]
4 A comparative review on heart ion channels, action potentials and electrocardiogram in rodents and human: extrapolation of experimental insights to clinic
Siyavash Joukar
Laboratory Animal Research. 2021; 37(1)
[Pubmed]  [Google Scholar] [DOI]
5 The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine
Aziza El Harchi, Andrew S. Butler, Yihong Zhang, Christopher E. Dempsey, Jules C. Hancox
Physiological Reports. 2020; 8(5)
[Pubmed]  [Google Scholar] [DOI]
6 Hydroxychloroquine in rheumatic autoimmune disorders and beyond
Eliise Laura Nirk, Fulvio Reggiori, Mario Mauthe
EMBO Molecular Medicine. 2020; 12(8)
[Pubmed]  [Google Scholar] [DOI]
7 Cardiac contractility modulation attenuates structural and electrical remodeling in a chronic heart failure rabbit model
Bin Ning, Feifei Zhang, Xuelian Song, Qingqing Hao, Yingxiao Li, Rong Li, Yi Dang
Journal of International Medical Research. 2020; 48(10): 0300060520
[Pubmed]  [Google Scholar] [DOI]
8 Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin
Alberto Cipriani, Alessandro Zorzi, Davide Ceccato, Federico Capone, Matteo Parolin, Filippo Donato, Paola Fioretto, Raffaele Pesavento, Lorenzo Previato, Pietro Maffei, Alois Saller, Angelo Avogaro, Cristiano Sarais, Dario Gregori, Sabino Iliceto, Roberto Vettor
International Journal of Cardiology. 2020; 316: 280
[Pubmed]  [Google Scholar] [DOI]
9 QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin
Brian C Hsia, Nicolas Greige, Jose A Quiroz, Ahmed S Khokhar, Johanna Daily, Luigi Di Biase, Kevin J Ferrick, John D Fisher, Andrew Krumerman
Journal of Interventional Cardiac Electrophysiology. 2020; 59(2): 337
[Pubmed]  [Google Scholar] [DOI]

 

Read this article